Perivascular spaces, glymphatic dysfunction, and small vessel disease

• Published in: Clinical science (1979) Vol. 131; no. 17; pp. 2257 - 2274
• Main Authors: Mestre, Humberto, Kostrikov, Serhii, Mehta, Rupal I., Nedergaard, Maiken
• Format: Journal Article
• Language: English
• Published: England 01.09.2017
• Subjects: Animals; Aquaporin 4 - genetics; Aquaporin 4 - metabolism; Blood Vessels - metabolism; Blood Vessels - physiopathology; Brain - metabolism; Brain - physiopathology; Cerebral Small Vessel Diseases - metabolism; Cerebral Small Vessel Diseases - physiopathology; Humans; CNS clearance; Cerebrospinal fluid; Small vessel disease; Perivascular space; Glymphatic
• ISSN: 0143-5221; 1470-8736; 1470-8736
• DOI: 10.1042/CS20160381

Cerebral small vessel diseases (SVDs) range broadly in etiology but share remarkably overlapping pathology. Features of SVD including enlarged perivascular spaces (EPVS) and formation of abluminal protein deposits cannot be completely explained by the putative pathophysiology. The recently discovered glymphatic system provides a new perspective to potentially address these gaps. This work provides a comprehensive review of the known factors that regulate glymphatic function and the disease mechanisms underlying glymphatic impairment emphasizing the role that aquaporin-4 (AQP4)-lined perivascular spaces (PVSs), cerebrovascular pulsatility, and metabolite clearance play in normal CNS physiology. This review also discusses the implications that glymphatic impairment may have on SVD inception and progression with the aim of exploring novel therapeutic targets and highlighting the key questions that remain to be answered.